A patient has become the first in the UK to receive a pioneering drug designed to delay the onset of Type 1 diabetes. Annette Quilter, from Shropshire, received the first NHS dose of Teplizumab at Queen Elizabeth Hospital Birmingham (QEHB) this week. The treatment can delay the progression...
A patient has become the first in the UK to receive a pioneering drug designed to delay the onset of Type 1 diabetes. Annette Quilter, from Shropshire, received the first NHS dose of Teplizumab at Queen Elizabeth Hospital Birmingham (QEHB) this week. The treatment can delay the progression...